BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 31744230)

  • 21. A study of ΔNp63 expression in lung non-small cell carcinomas.
    Nonaka D
    Am J Surg Pathol; 2012 Jun; 36(6):895-9. PubMed ID: 22367298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of P63 and its correlation with prognosis in diffuse large B-cell lymphoma: a single center experience.
    Hu WM; Jin JT; Wu CY; Lu JB; Zhang LH; Zeng J; Lin SX
    Diagn Pathol; 2019 Nov; 14(1):128. PubMed ID: 31711519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The magnitude of COVID-19's effect on the timely management of melanoma and nonmelanoma skin cancers.
    Marson JW; Maner BS; Harding TP; Meisenheimer J; Solomon JA; Leavitt M; Levin NJ; Dellavalle R; Brooks I; Rigel DS
    J Am Acad Dermatol; 2021 Apr; 84(4):1100-1103. PubMed ID: 33482258
    [No Abstract]   [Full Text] [Related]  

  • 24. Cutaneous neoplasms; early detection.
    Mysliborski JA
    N Y State J Med; 1980 Oct; 80(11):1716-20. PubMed ID: 6939978
    [No Abstract]   [Full Text] [Related]  

  • 25. Common skin cancers.
    Richardson D; Lumpkin LR
    Am Fam Physician; 1977 Jun; 15(6):114-5. PubMed ID: 868724
    [No Abstract]   [Full Text] [Related]  

  • 26. Common skin cancers in older adults: approach to diagnosis and management.
    Council ML
    Clin Geriatr Med; 2013 May; 29(2):361-72. PubMed ID: 23571033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunocytochemical p63 expression discriminates between primary cutaneous follicle centre cell and diffuse large B cell lymphoma-leg type, and is of the TAp63 isoform.
    Robson A; Shukur Z; Ally M; Kluk J; Liu K; Pincus L; Sahni D; Sundram U; Subtil A; Karai L; Kempf W; Schieke S; Coates P
    Histopathology; 2016 Jul; 69(1):11-9. PubMed ID: 26332336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Family matters: sibling rivalry and bonding between p53 and p63 in cancer.
    Romano RA; Sinha S
    Exp Dermatol; 2014 Apr; 23(4):238-9. PubMed ID: 24690037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Head-to-Head Comparison of p63 and p40 in Non-Neuroendocrine Carcinomas of the Tubal Gut.
    Bakhshwin AM; Gordon IO; Brown KB; Liu X; Allende DS
    Int J Surg Pathol; 2020 Dec; 28(8):835-843. PubMed ID: 32466705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Implications of High-mobility Group Box-1 (HMGB1) and the Receptor for Advanced Glycation End-products (RAGE) in Cutaneous Malignancy: A Systematic Review.
    Nguyen AH; Detty SQ; Agrawal DK
    Anticancer Res; 2017 Jan; 37(1):1-7. PubMed ID: 28011467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Early diagnosis of skin cancer].
    Kolm I; Hofbauer G; Braun RP
    Ther Umsch; 2010 Sep; 67(9):439-46. PubMed ID: 20806172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recognition for the diagnosis of skin cancer.
    Usatine RP
    J Fam Pract; 2003 Mar; 52(3):219-21. PubMed ID: 12620176
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinicopathology significance of p53 and p63 expression in Indonesian cervical squamous cell carcinomas.
    Romus I; Triningsih FE; Mangunsudirdjo S; Harijadi A
    Asian Pac J Cancer Prev; 2013; 14(12):7737-41. PubMed ID: 24460361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P40 Immunostain Does Not Outperform p63 as a Myoepithelial Cell Marker in the Daily Practice of Breast Pathology.
    Khazai L; Agosto-Arroyo E; Rosa M
    Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):599-604. PubMed ID: 28549030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recognising Skin Cancer in Primary Care.
    Jones OT; Ranmuthu CKI; Hall PN; Funston G; Walter FM
    Adv Ther; 2020 Jan; 37(1):603-616. PubMed ID: 31734824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The big three of skin cancer: basal cell carcinoma, squamous cell carcinoma, and malignant melanoma.
    Robinson JK; Roenigk HH
    Postgrad Med; 1980 Jun; 67(6):92-7, 100-2, 105-7. PubMed ID: 7375418
    [No Abstract]   [Full Text] [Related]  

  • 37. Identifying and treating skin malignancies.
    Jessen RT; Merwin CF
    Geriatrics; 1979 Jun; 34(6):71-8. PubMed ID: 447078
    [No Abstract]   [Full Text] [Related]  

  • 38. N-Glycosylation in progression of skin cancer.
    Tang L; Chen X; Zhang X; Guo Y; Su J; Zhang J; Peng C; Chen X
    Med Oncol; 2019 Apr; 36(6):50. PubMed ID: 31037368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of skin cancers 2: malignant lesions.
    Freak J
    Br J Community Nurs; 2005 Feb; 10(2):58-64. PubMed ID: 15788942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sialic acid differential expression in non-melanoma skin cancer biopsies.
    Ferreira SA; Vasconcelos JL; Cavalcanti CL; Rêgo MJ; Beltrão EI
    Med Mol Morphol; 2013 Dec; 46(4):198-202. PubMed ID: 23508708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.